Upgrade to SI Premium - Free Trial

Globus Medical (GMED) PT Raised to $117 at Needham

May 8, 2026 6:18 AM
Needham analyst Mike Matson raised the price target on Globus Medical (NYSE: GMED) to $117.00 (from $114.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change